Benefit of IVIg for long-standing ataxic sensory neuronopathy with Sjögren's syndrome.
Wolfe
Gil I
GI
Nations
Sharon P
SP
Burns
Dennis K
DK
Herbelin
Laura L
LL
Barohn
Richard J
RJ
D000328:Adult; D020274:Autoimmune Diseases of the Nervous System / Q000235:genetics / Q000628:therapy*; D005260:Female; D020234:Gait Ataxia / Q000209:etiology* / Q000628:therapy; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use*; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D011115:Polyneuropathies / Q000209:etiology* / Q000628:therapy; D012074:Remission Induction; D012678:Sensation Disorders / Q000209:etiology* / Q000628:therapy; D012859:Sjogren's Syndrome / Q000150:complications / Q000235:genetics / Q000628:therapy*
D016756:Immunoglobulins, Intravenous; D007166:Immunosuppressive Agents